Breast Cancer | Specialty

The OncLive Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Relapsed/Refractory HER2+ mBC: Evolving Treatment Landscape

May 18th 2020

Dr. Wright on Radiation Considerations in Breast Cancer

May 15th 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

Dr. Wright on Radiation Considerations in Breast Cancer

May 14th 2020

Jean Wright, MD, discusses radiation considerations in breast cancer.

Looking Forward to a New Wave of Breast Cancer Therapies

May 14th 2020

The degree to which nature and nurture affect disease has long been debated in medicine, and it is an issue that esteemed breast cancer researcher and medical oncologist Joyce A. O’Shaughnessy, MD, has been working to unravel for her patients throughout a career that spans more than 30 years.

Dr. Gayle on Current Treatment Options in Breast Implant-Associated ALCL

May 13th 2020

Lloyd B. Gayle, MD, discusses current treatment options for patients who develop breast implant–associated anaplastic large cell lymphoma (ALCL).

Tucatinib Approved in Switzerland for HER2-Positive Breast Cancer

May 12th 2020

Tucatinib has been approved in Switzerland for use in combination with trastuzumab and capecitabine for patients with previously treated metastatic HER2-positive breast cancer.

Dr. Accordino on Utility of Liquid Biopsies in Breast Cancer

May 9th 2020

Melissa K. Accordino, MD, MS, discusses the utility of liquid biopsies in breast cancer.

Optimizing Perioperative Treatment Strategies in TNBC

May 8th 2020

TNBC: Using Checkpoint Inhibitors Alone or With Chemotherapy

May 8th 2020

IMpassion130: Addressing Immune-Related AEs in TNBC Management

May 8th 2020

Analysis of IMpassion130: PD-L1 Testing in Advanced TNBC

May 8th 2020

TNBC: Updated Efficacy Results From IMpassion130

May 8th 2020

Adjuvant I/O in TNBC

May 8th 2020

ICI Combination Therapy Versus Monotherapy

May 8th 2020

PD-L1 Immune-Related Adverse Events

May 8th 2020

PD-L1 Assay PFS and OS Concordance

May 8th 2020

IMpassion130: Design and Preliminary Efficacy

May 8th 2020

Dr. Tolaney on Remaining Questions With CDK4/6 Inhibitors in HR+/HER2- Breast Cancer

May 5th 2020

Sara M. Tolaney, MD, MPH, discusses remaining questions with CDK4/6 inhibitors in hormone receptor–positive, HER2-negative metastatic breast cancer.

Breast Cancer Guidelines Carve Out Category for Low ER Expression

May 4th 2020

The American Society of Clinical Oncology and College of American Pathologists have further refined their recommendations for estrogen receptor and progesterone receptor testing protocols in patients with breast cancer.

Dr. Wright on Proton Versus Photon Radiotherapy in Breast Cancer

May 2nd 2020

Jean Wright, MD, discusses proton versus photon radiotherapy in breast cancer.